A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
IntroductionAllogeneic chimeric antigen receptor T (CAR-T) therapy, also known as universal CAR-T (UCAR-T) therapy, offers broad applicability, high production efficiency, and reduced costs, enabling quicker access for patients. However, clinical appli…